Interest rate sensitive, auto, banking and realty stocks will be in focus ahead of the Reserve Bank of India (RBI)'s monetary policy review today, 3 June 2014. The RBI left its main lending rate viz. the repo rate unchanged at 8% after a monetary policy review on 1 April 2014 as consumer-price inflation eased to a two-year low and as the rupee firmed up against the dollar.
Tata Motors' total sales (including exports) of Tata commercial and passenger vehicles fell 24% to 37,525 vehicles in May 2014 over May 2013. The company's domestic sales of Tata commercial and passenger vehicles fell 24% to 34,334 units in May 2014 over May 2013. The company's sales of commercial vehicles fell 27% to 25,104 units in May 2014 over May 2013. The company's sales from exports fell 18% to 3,191 units in May 2014 over May 2013.
Tata Motors after trading hours on Monday, 2 June 2014, said that Mr Ravi Kant has retired as Non-Executive Vice Chairman from the company's board of directors on 31 May 2014 on attaining the age of 70 as per the company's retirement policy. The board of directors placed on record their appreciation of Mr Kant's contribution during his tenure with the company including as Managing Director for the period 29 July 2005 to 1 June 2009 and thereafter in his capacity as Non-Executive Vice Chairman, Tata Motors said in a statement.
Ashok Leyland said its total sales fell 9% to 6632 units in May 2014 over May 2013. Total sales of medium and heavy commercial vehicles (M&HCV) fell 1% to 4,884 units, while total sales of light commercial vehicles (LCV) declined 25% to 1,748 units in May 2014 over May 2013.
Escorts said its Agri Machinery Segment sold 5,794 tractors in May 2014 compared with 6,188 tractors in May 2013. Domestic sales stood at 5,704 tractors in May 2014 as against 6,122 tractors in May 2013. Exports stood at 90 tractors in May 2014 as that of 66 tractors in May 2013.
Zee Entertainment Enterprises will be in focus after the Reserve Bank of India on Monday, 2 June 2014, said that foreign institutional investors (FIIs) can now invest up to 100% of the paid up capital of Zee Entertainment Enterprises under the Portfolio Investment Scheme, which is higher than the earlier ceiling of 49%. Zee Entertainment Enterprises has passed resolutions at its Board of Directors' level and a special resolution by the shareholders, agreeing for enhancing the limit for the purchase of its equity shares and convertible debentures by FIIs. This approval is given subject to the condition that the onus of compliance with FDI policy and FEMA regulations, including downstream investment would continue to remain on Zee Entertainment Enterprises, the Reserve Bank of India said in a press release.
ITC turns ex-dividend for a dividend of Rs 6 per share for the financial year ended 31 March 2014
More From This Section
Bharti Airtel is reportedly likely to conclude a deal to sell its towers in Africa in seven days, which could help the company garner as much as $3 billion and help reduce debt. According to reports, Bharti Airtel has already shortlisted buyers from among four tower companies Helios Towers Africa, IHS, American Tower Corp and Eaton Towers for the sale.
Ipca Laboratories and Oncobiologics, Inc., USA (Oncobiologics) after trading hours on Monday, 2 June 2014, announced the creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The financial terms of the agreement between the two companies were not disclosed. Under the first part of the agreement, Ipca will in-license and commercialize biosimilar products for India and other associated markets. These products will be developed by Oncobiologics to USFDA and EU regulatory standards for global commercialization. Initial manufacturing will occur in the US by Oncobiologics and later by Ipca in India. The biologics covered by the agreement are among the most popular therapies in the world for immunology and oncology disease indications, Ipca said in statement. The partnership is planning to launch the first product in 2017, the Indian pharmaceutical company said.
Under the second part of the agreement, Oncobiologics will replicate its biologics R&D and manufacturing facility in India to create a world-class capability for Ipca for further biosimilar commercialization. The Mumbai R&D facility will be designed for development and commercialization of complex monoclonal antibodies. The manufacturing facility will be located in Vadodara and will utilize the latest single-use manufacturing platform, Ipca said. The R&D facility will be operational from 2015 and the manufacturing facility will be operational by 2016.
Gammon Infrastructure Projects said that its board has decided not to pursue the amalgamation of the Pravara Renewable Energy with the company.
Promoters of Hubtown have offered to sell an aggregate of 54.48 lakh equity shares, representing 7.49% of the paid-up equity share capital of the company, as on 2 June 2014. The sale shall take place on the separate trading window of BSE and shall commence on 4 June 2014 at 9.15 IST and shall close on the same day at 3.30 IST.
MTNL said that A. K. Garg has ceased to be the CMD of the company with effect from 31 May 2014 on account of retirement on attaining the age of superannuation.
Powered by Capital Market - Live News